• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坎地沙坦和其他 AT(1)受体阻滞剂在洗脱后抑制血管紧张素 II 诱导的 AT(1)受体激活的能力。

Abilities of candesartan and other AT(1) receptor blockers to impair angiotensin II-induced AT(1) receptor activation after wash-out.

机构信息

Department of Cardiology, Fukuoka University School of Medicine, Jonan-ku, Fukuoka, Japan.

出版信息

J Renin Angiotensin Aldosterone Syst. 2012 Mar;13(1):76-83. doi: 10.1177/1470320311417478. Epub 2011 Aug 8.

DOI:10.1177/1470320311417478
PMID:21824992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3891522/
Abstract

Angiotensin II (Ang II) binds to Ang II type 1 (AT(1)) receptor and evokes cell signaling, and subsequently stimulates vasoconstriction and cell proliferation, which eventually lead to cardiovascular disease. Since most AT(1) receptor blockers (ARBs) have molecular (differential) effects, we evaluated the specific features of candesartan and compared the abilities of candesartan and other ARBs (olmesartan, telmisartan, valsartan, irbesartan and losartan) to bind to and activate AT(1) receptors using a cell-based wash-out assay. Each ARB blocked Ang II-induced extracellular signal-regulated kinase (ERK) activation and inositol phosphate production to different degrees after wash-out. In addition, a small difference in the molecular structure, i.e. a carboxyl group, between candesartan and candesartan-7H was associated with a difference in the degree of this blocking effect. In addition, interaction between Gln(257) in the AT(1) receptor and the carboxyl group of candesartan may be partially associated with the effect of candesartan after wash-out. Although our findings regarding the molecular effects of ARB are based on basic research, these findings may lead to an exciting new area in the clinical application of ARBs.

摘要

血管紧张素 II(Ang II)与血管紧张素 II 型 1(AT(1))受体结合并引发细胞信号转导,随后刺激血管收缩和细胞增殖,最终导致心血管疾病。由于大多数 AT(1)受体阻滞剂(ARB)具有分子(差异)作用,我们评估了坎地沙坦的特异性,并使用基于细胞的洗脱测定法比较了坎地沙坦和其他 ARB(奥美沙坦、替米沙坦、缬沙坦、厄贝沙坦和氯沙坦)与 AT(1)受体结合和激活的能力。在洗脱后,每种 ARB 都不同程度地阻断了 Ang II 诱导的细胞外信号调节激酶(ERK)激活和肌醇磷酸生成。此外,坎地沙坦和坎地沙坦-7H 之间分子结构上的微小差异,即羧基,与这种阻断作用的程度差异有关。此外,AT(1)受体中的 Gln(257)与坎地沙坦的羧基之间的相互作用可能与洗脱后坎地沙坦的作用部分相关。尽管我们关于 ARB 分子作用的发现基于基础研究,但这些发现可能会为 ARB 的临床应用开辟一个令人兴奋的新领域。

相似文献

1
Abilities of candesartan and other AT(1) receptor blockers to impair angiotensin II-induced AT(1) receptor activation after wash-out.坎地沙坦和其他 AT(1)受体阻滞剂在洗脱后抑制血管紧张素 II 诱导的 AT(1)受体激活的能力。
J Renin Angiotensin Aldosterone Syst. 2012 Mar;13(1):76-83. doi: 10.1177/1470320311417478. Epub 2011 Aug 8.
2
Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.不同来源离体血管中各种血管紧张素Ⅱ1型受体阻滞剂的作用机制差异
Hypertension. 1999 Jun;33(6):1406-13. doi: 10.1161/01.hyp.33.6.1406.
3
Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan.与坎地沙坦相比,最近获批的血管紧张素 II 受体拮抗剂阿齐沙坦具有独特的结合行为。
Hypertens Res. 2013 Feb;36(2):134-9. doi: 10.1038/hr.2012.147. Epub 2012 Oct 4.
4
Ability of the new AT1 receptor blocker azilsartan to block angiotensin II-induced AT1 receptor activation after wash-out.新型 AT1 受体阻滞剂阿齐沙坦在洗脱后阻断血管紧张素 II 诱导的 AT1 受体激活的能力。
J Renin Angiotensin Aldosterone Syst. 2014 Mar;15(1):7-12. doi: 10.1177/1470320313482170. Epub 2013 Apr 5.
5
Female spontaneously hypertensive rats are more dependent on ANG (1-7) to mediate effects of low-dose AT1 receptor blockade than males.雌性自发性高血压大鼠比雄性大鼠更依赖 ANG(1-7)来介导低剂量 AT1 受体阻断的作用。
Am J Physiol Renal Physiol. 2014 May 15;306(10):F1136-42. doi: 10.1152/ajprenal.00677.2013. Epub 2014 Mar 19.
6
Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor.奥美沙坦与替米沙坦和人血管紧张素II 1型受体之间相互作用的分子特征
Br J Pharmacol. 2007 Aug;151(7):952-62. doi: 10.1038/sj.bjp.0707323. Epub 2007 Jun 18.
7
The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.不同血管紧张素II 1型受体阻滞剂对雄性小鼠压力超负荷诱导的心脏重塑中ACE-AngII-AT1和ACE2-Ang(1-7)-Mas轴调节的影响。
J Mol Cell Cardiol. 2016 Aug;97:180-90. doi: 10.1016/j.yjmcc.2016.05.012. Epub 2016 May 19.
8
AT1 receptor blocker potentiates shear-stress induced nitric oxide production via modulation of eNOS phosphorylation of residues Thr(495) and Ser(1177.).血管紧张素受体阻滞剂通过调节内皮型一氧化氮合酶丝氨酸 1177 和苏氨酸 495 位的磷酸化增强切应力诱导的一氧化氮产生。
Biochem Biophys Res Commun. 2013 Nov 29;441(4):713-9. doi: 10.1016/j.bbrc.2013.10.108. Epub 2013 Nov 6.
9
Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.血管紧张素II 1型受体拮抗剂体外对人血小板活化的比较作用。
J Cardiovasc Pharmacol. 2000 Jun;35(6):906-13. doi: 10.1097/00005344-200006000-00012.
10
Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors.血管紧张素受体拮抗剂在表达人血管紧张素II 1型受体的中国仓鼠卵巢细胞上的可逆性和同位相互作用。
Biochem Pharmacol. 2000 Apr 15;59(8):927-35. doi: 10.1016/s0006-2952(99)00403-7.

本文引用的文献

1
A small difference in the molecular structure of angiotensin II receptor blockers induces AT₁ receptor-dependent and -independent beneficial effects.血管紧张素 II 受体阻滞剂的分子结构略有差异,可引起 AT₁ 受体依赖性和非依赖性的有益作用。
Hypertens Res. 2010 Oct;33(10):1044-52. doi: 10.1038/hr.2010.135. Epub 2010 Jul 29.
2
Review: angiotensin II type 1 receptor blockers: class effects versus molecular effects.综述:血管紧张素 II 型 1 受体阻滞剂:类效应与分子效应。
J Renin Angiotensin Aldosterone Syst. 2011 Mar;12(1):1-7. doi: 10.1177/1470320310370852. Epub 2010 Jul 5.
3
Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial.
糖尿病和肥胖在坎地沙坦降压生存评估在日本(CASE-J)试验中的作用。
Hypertens Res. 2010 Jun;33(6):600-6. doi: 10.1038/hr.2010.38. Epub 2010 Apr 9.
4
Binding sites of valsartan, candesartan and losartan with angiotensin II receptor 1 subtype by molecular modeling.通过分子模拟研究缬沙坦、坎地沙坦和氯沙坦与血管紧张素II受体1亚型的结合位点。
Life Sci. 2009 Jul 17;85(3-4):136-40. doi: 10.1016/j.lfs.2009.05.001. Epub 2009 May 14.
5
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009).日本高血压学会高血压管理指南(JSH 2009)
Hypertens Res. 2009 Jan;32(1):3-107.
6
Sartan-AT1 receptor interactions: in vitro evidence for insurmountable antagonism and inverse agonism.沙坦类药物与AT1受体的相互作用:不可克服的拮抗作用和反向激动作用的体外证据
Mol Cell Endocrinol. 2009 Apr 29;302(2):237-43. doi: 10.1016/j.mce.2008.06.006. Epub 2008 Jun 21.
7
Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation.机械应力诱导激活背后的血管紧张素II 1型受体构象转换。
EMBO Rep. 2008 Feb;9(2):179-86. doi: 10.1038/sj.embor.7401157. Epub 2008 Jan 18.
8
Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring.血管紧张素II AT1受体拮抗剂的降压活性:一项采用24小时动态血压监测的研究的系统评价
J Hypertens. 2007 Jul;25(7):1327-36. doi: 10.1097/HJH.0b013e3280825625.
9
Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor.血管紧张素II 1型受体反向激动剂的分子机制
J Biol Chem. 2006 Jul 14;281(28):19288-95. doi: 10.1074/jbc.M602144200. Epub 2006 May 10.
10
Structure-activity relationships of inverse agonists for G-protein-coupled receptors.G蛋白偶联受体反向激动剂的构效关系
Med Res Rev. 2005 Jul;25(4):398-426. doi: 10.1002/med.20031.